ALT phenotype assessment in IDH-mutant astrocytoma supports biologic consequence of ATRX missense mutations.

Abstract

A meaningful subset of IDH-mutant astrocytoma harbors ATRX missense variants that retain ATRX IHC immunoreactivity yet exhibit functional ALT activation, supporting the biologic relevance of these missense mutations.